RECRUITINGINTERVENTIONAL
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial
About This Trial
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
Who May Be Eligible (Plain English)
Who May Qualify:
- Youth with a DSM-5 diagnosis of MDE
Who Should NOT Join This Trial:
- Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
- Allergic to omega-3 fatty acids
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Youth with a DSM-5 diagnosis of MDE
Exclusion Criteria:
* Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
* Allergic to omega-3 fatty acids
Treatments Being Tested
COMBINATION_PRODUCT
Omega-3 fatty acids
omega-3 fatty acids (EPA)
DIETARY_SUPPLEMENT
Placebo
soy bean oil
Locations (1)
China Medical University
Taichung, Taichung, Taiwan